[go: up one dir, main page]

ES2019552A6 - Procedimiento para la preparacion de glicerofosfolipidos. - Google Patents

Procedimiento para la preparacion de glicerofosfolipidos.

Info

Publication number
ES2019552A6
ES2019552A6 ES9001051A ES9001051A ES2019552A6 ES 2019552 A6 ES2019552 A6 ES 2019552A6 ES 9001051 A ES9001051 A ES 9001051A ES 9001051 A ES9001051 A ES 9001051A ES 2019552 A6 ES2019552 A6 ES 2019552A6
Authority
ES
Spain
Prior art keywords
group
hydrogen
carbon atoms
glycerophospholipids
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9001051A
Other languages
English (en)
Inventor
Federico M Arcamone
Germano Carganico
Perez Luisa Garcia
Torro Amparo Fos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Priority to ES9001051A priority Critical patent/ES2019552A6/es
Publication of ES2019552A6 publication Critical patent/ES2019552A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE GLICEROFOSFOLIPIDOS. CONSISTE EN UN PROCEDIMIENTO PARA OBTENER NUEVOS GLICEROFOSFOLIPIDOS REPRESENTADOS POR LA FORMULA: FORMULA DONDE R REPRESENTA UN GRUPO CARBOXILO, CIANO ALCOXICARBONILO, ARILALCOXICARBONILO O ARILOXICARBONILO DE 1 A 15 ATOMOS DE CARBONO, O UN GRUPO CONRSIARSIB, DONDE RSIA Y RSIB, IGUALES O DIFERENTES ENTRE SI, SON HIDROGENO O UN GRUPO ALQUILO DE 1 A 6 ATOMOS DE CARBONO; N ES UN ENTERO ENTRE 4 Y 10; RBSI ES HIDROGENO, O UN GRUPO ALQUILO O ARALQUILO DE 1 A 22 ATOMOS DE CARBONO; RBSII ES HIDROGENO O UN GRUPO ALQUILO DE 1 A 6 ATOMOS DE CARBONO; Y RBSIII ES HIDROGENO, CARBOXILO, ALCOXICARBONILO, ARILALCOXICARBONILO O ARILOXICARBONILO DE 1 A 15 ATOMOS DE CARBONO, O UN GRUPO CONRSIARSIB COMO SE HA DEFINIDO ARRIBA. DICHOS COMPUESTOS PUEDEN SER UTILIZADOS COMO ANTITUMORALES, REGULADORES DE LA ACTIVIDAD DE LOS GLUCOCORTICOIDES, ANTIASMATICOS, ANTITROMBOTICOS, ANTIINFLAMATORIOS, ANTIALERGICOS Y EN LA PREVENCION DEL SHOCK ANAFILACTICO.
ES9001051A 1990-04-11 1990-04-11 Procedimiento para la preparacion de glicerofosfolipidos. Expired - Lifetime ES2019552A6 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9001051A ES2019552A6 (es) 1990-04-11 1990-04-11 Procedimiento para la preparacion de glicerofosfolipidos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9001051A ES2019552A6 (es) 1990-04-11 1990-04-11 Procedimiento para la preparacion de glicerofosfolipidos.

Publications (1)

Publication Number Publication Date
ES2019552A6 true ES2019552A6 (es) 1991-06-16

Family

ID=8266854

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9001051A Expired - Lifetime ES2019552A6 (es) 1990-04-11 1990-04-11 Procedimiento para la preparacion de glicerofosfolipidos.

Country Status (1)

Country Link
ES (1) ES2019552A6 (es)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2034885A1 (es) * 1991-07-10 1993-04-01 Menarini Lab Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.
EP1341543A4 (en) * 2000-11-24 2009-09-02 Vascular Biogenics Ltd METHODS INVOLVING DEFINED OXIDE PHOSPHOLIPIDS, AND COMPOSITIONS CONTAINING THE SAME, FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
EP1626728A4 (en) * 2003-05-27 2009-09-02 Vascular Biogenics Ltd OXIDIZED LIPIDS AND THEIR USES IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS
US8206743B2 (en) 2000-11-17 2012-06-26 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
US8415318B2 (en) 2001-10-19 2013-04-09 Vascular Biogenics Ltd. Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
US8569529B2 (en) 2007-01-09 2013-10-29 Vascular Biogenics Ltd. High-purity phospholipids
US8759557B2 (en) 2004-07-09 2014-06-24 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
US9006217B2 (en) 2007-01-09 2015-04-14 Vascular Biogenics Ltd. High-purity phospholipids
US9206206B2 (en) 2008-11-06 2015-12-08 Vascular Biogenics Ltd. Oxidized lipid compounds and uses thereof
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
US10022388B2 (en) 2014-11-26 2018-07-17 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of fibrosis

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2034885A1 (es) * 1991-07-10 1993-04-01 Menarini Lab Procedimiento para la preparacion de cetoalquilglicerofosfolipidos.
US8206743B2 (en) 2000-11-17 2012-06-26 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
EP1341543A4 (en) * 2000-11-24 2009-09-02 Vascular Biogenics Ltd METHODS INVOLVING DEFINED OXIDE PHOSPHOLIPIDS, AND COMPOSITIONS CONTAINING THE SAME, FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
US8563534B2 (en) 2000-11-24 2013-10-22 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
US7893291B2 (en) 2000-11-24 2011-02-22 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
EP2425841A1 (en) * 2000-11-24 2012-03-07 Vascular Biogenics Ltd. Methods Employing and Compositions Containing Defined Oxidized Phospholipids for Prevention and Treatment of Atherosclerosis
US8158611B2 (en) 2000-11-24 2012-04-17 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
US8415318B2 (en) 2001-10-19 2013-04-09 Vascular Biogenics Ltd. Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
US8501715B2 (en) 2003-05-27 2013-08-06 Vascular Biogenics Ltd. Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
US7902176B2 (en) 2003-05-27 2011-03-08 Vascular Biogenics Ltd. Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
EP1626728A4 (en) * 2003-05-27 2009-09-02 Vascular Biogenics Ltd OXIDIZED LIPIDS AND THEIR USES IN THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS
US7973023B2 (en) 2003-05-27 2011-07-05 Vascular Biogenics Ltd. Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
US8802875B2 (en) 2004-07-09 2014-08-12 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
US8759557B2 (en) 2004-07-09 2014-06-24 Vascular Biogenics Ltd. Process for the preparation of oxidized phospholipids
US9006217B2 (en) 2007-01-09 2015-04-14 Vascular Biogenics Ltd. High-purity phospholipids
US8569529B2 (en) 2007-01-09 2013-10-29 Vascular Biogenics Ltd. High-purity phospholipids
US9566288B2 (en) 2007-01-09 2017-02-14 Vascular Biogenics Ltd. High-purity phospholipids
US9206206B2 (en) 2008-11-06 2015-12-08 Vascular Biogenics Ltd. Oxidized lipid compounds and uses thereof
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
US10022388B2 (en) 2014-11-26 2018-07-17 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of fibrosis
US10206936B2 (en) 2014-11-26 2019-02-19 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of fibrosis
US10464957B2 (en) 2014-11-26 2019-11-05 Vascular Biogenics Ltd. Oxidized lipids and methods of use thereof

Similar Documents

Publication Publication Date Title
PH20468A (en) Novel pharmaceutically active di-esters of 3,5-dicarboxy-4-substituted-pyridines and pyrans
AU588972B2 (en) New derivatives of 1,2,5,6-tetrahydropyridine-3- carboxaldehyde oxime, their preparation process, their use as medicaments, and the compositions containing them
ZA918570B (en) Azasteroid compounds for the treatment of prostatic hypertrophy,their preparation and use
ES448263A1 (es) Procedimiento para la obtencion de materiales sinteticos de poliuretano.
ES2019552A6 (es) Procedimiento para la preparacion de glicerofosfolipidos.
ES8104321A1 (es) Procedimiento para separar un derivado de alquil-cetohexopi-ranosida
ES482005A1 (es) Procedimiento para preparar una composicion tensioactiva de-alcoxi-bis (trialcoxisiloxi)- silano.
ES8104391A1 (es) Un procedimiento para preparar una composicion tensioactiva de baja formacion de espuma
ES476048A1 (es) Procedimiento para preparar sales de amonio cuaternario
EP0347930A3 (en) Metallic pigment composition
DE3372095D1 (en) Novel phenylpiperazine derivatives and process for producing the same
AU543519B2 (en) New peptide amides and process for their manufacture
ES471267A1 (es) Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos
DE2962829D1 (en) Isomerisation of 3-azabicyclo(3.1.0)hexane derivatives
ES8401957A1 (es) Procedimiento de preparacion de derivados del acido 2-tiofen-acetico.
US4198500A (en) Trans-4,5-didehydro-PGI1 amides
AU5521086A (en) Novel diamine derivatives
HU9401470D0 (en) 1-phenylpyrrolidone derivatives, intermediates for producing them and producing them
JPS55100384A (en) Cephalosporin analog
GR3000378T3 (en) Alpha-allyl substituted arylalkyltriazoles, process for their preparation and their use as fungicides
TW333554B (en) Benzidine derivative and electrophotosensitive material using the same
ES445149A1 (es) Procedimiento de preparacion de nuevos derivados de 5-tia- zol-alcanoles.
ES482419A1 (es) Un procedimiento para la preparacion de eteres del acido - clavulanico.
PH19547A (en) Derivatives of 2-butyrolactone for protecting the myocardium presenting an anti-arrythmic activity and drugs containing same
ES8404989A1 (es) Un procedimiento para preparar 4-(2-hidroxietil)-2-azetidinona opticamente activa.